Changes in Hemoglobin, Mean Thrombocid Volume and Neutrophil-Lymphocyte Ratio in Covıd-19 Infection

Abstract

Objective: It is aimed to evaluate the changes in blood and inflammatory markers (Mean Platelet Volume and Neutrophil Lymphocyte Ratio) in COVID-19. Method: We studied a total of 213 patients. 142 of them consist of patients who have undergone PCR test due to COVID-19 complaints and have a definite diagnosis. The blood values of 71 healthy people of similar age and characteristics without any complaints or symptoms were retrospectively compared. Results: The mean age of the COVID-19(+) group was 54.62±17.71 years, while the COVID-19(-) group was 50.54±15.74 years. 52.8% (n:75) of the patient group and 54.9% (n:39) of the COVID-19(-) group were women. There was a decrease in the number of platelets especially in the PCR(+) group, but statistically no significant difference was observed between the PCR(+) group and the COVID-19(-) group for hemoglobin and platelet values (p>0.05). However, a significant difference (p <0.01) was found in Mean Platelet Volume, neutrophil, lymphocyte and Neutrophil Lymphocyte Ratio. Conclusion: Due to the cytokine storm that develops in COVID-19 infection, a number of changes occur in the blood, especially a decrease in thrombocyte counts. We think that especially the changes in Mean Platelet Volume and Neutrophil Lymphocyte Ratio, which are new inflammatory markers, can be used in the follow-up of this disease and its prognosis.

Keywords

• COVID-19
• hemoglobin
• platelet
• neutrophil
• lymphocyte

Project Number

Yok

COVID-19’da Hemoglobin, Ortalama Trombosit Hacimleri ve Nötrofil Lenfosit Oranındaki Değişiklikler

Abstract

Amaç: Dünya genelinde büyük bir salgın yapan COVID-19 hastalığında, kanda ve inflamatuvar belirteçlerde (Ortalama Trombosit Hacmi ve Nötrofil Lenfosit Oranı) meydana gelen değişimleri değerlendirmek amaçlanmıştır. Yöntem: Çalışma, toplam 213 kişi ile yapılmıştır. Bunların 142 kişisi COVID-19 şikâyetleri nedeniyle Real Time Polimeraz Zincir Reaksiyonu (PCR) testi yapılmış ve kesin tanısı konmuş hastalardan oluşmaktadır. Benzer yaş ve özellikte hiçbir şikayet ve semptomu olmayan 71 adet sağlıklı insanın kan değerleri ile retrospektif olarak karşılaştırılmıştır. Bulgular: COVID-19 pozitif grubun yaş ortalaması 54.62±17.71 yıl iken kontrol grubunun 50.54±15.74 yıl idi. Hasta grubunun %52,8’si (n:75) kontrol grubunun ise %54,9’u (n:39) kadınlardan oluşmaktaydı. Özellikle PCR pozitif grupta platelet sayılarında düşüş saptanmıştır ama istatiksel açıdan PCR pozitif grup ile kontrol grubu arasında hemoglobin ve platelet değerleri için anlamlı bir farklılık gözlenmemiştir (p>0,05). Ama Ortalama Trombosit Hacmi, nötrofil, lenfosit ve nötrofil lenfosit oranlarında anlamlı farklılık (p<0,01) saptanmıştır. Sonuç: COVID-19 enfeksiyonunda gelişen sitokin fırtınası nedeniyle kanda trombosit sayılarında azalma başta olmak üzere bir dizi değişiklikler meydana gelmektedir. Özellikle yeni inflamatuvar markerlerdan olan Ortalama Trombosit Hacmi ve Nötrofil Lenfosit Oranında meydana gelen değişiklikler bu hastalığın ve prognozunun takibinde kullanılabileceğini düşünmekteyiz.

Keywords

• Covid 19
• hemoglobin
• trombosit
• nötrofil
• lenfosit

Supporting Institution

Yok

Project Number

Yok

Thanks

Yok

References

1. Kaul D. An overview of coronaviruses including the SARS-2 coronavirus-molecular biology, epidemiology and clinical implications. Curr Med Res Pract. 2020;10(2):54–64. doi: 10.1016/j.cmrp.2020.04.001
2. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-1207. doi: 10.1056/NEJMoa2001316
3. Chen J, Wang R, Wang M, Wei GW. Mutations strengthened SARS-CoV-2 infectivity. J Mol Biol. 2019;432(19):5212–5226. doi: 10.1016/j.jmb.2020.07.009
4. Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): New perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm. 2019;9213074. doi: 10.1155/2019/9213074
5. Mete E, Akelma AZ, Cizmeci MN, Bozkaya D, Kanburoglu MK. Decreased mean platelet volume in children with acute rotavirus gastroenteritis. Platelets. 2014;25(1):51-54. doi: 10.3109/09537104.2013.764493.
6. Coban E,Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract. 2005;59(8):981–982. doi: 10.1111/j.1742-1241.2005.00500.x
7. Toplak H, Wascher TC. Influence of weight reduction on platelet volume: Different effects of a hypocaloric diet and a very low calorie diet. Eur J Clin Invest. 1994;24(11):778-780. doi: 10.1111/j.1365-2362.1994.tb01076.x
8. Abuhandan M, Gümüş H, Solmaz A, Güzel B. Vitamin B12 eksikliğinde hastalarda ortalama trombosit volümün değerlendirilmesi. Harran Üniversitesi Tıp Fakültesi Dergisi. 2014; 11(3): 253-256.

9. Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008;75(3):291-294. doi: 10.1016/j.jbspin.2007.06.016
10. Chen X, Li J, Zhang X, Liu Y, Wu J, Li Y, et al. Prognostic and clinicopathological significance of pretreatment mean platelet volume in cancer: A meta-analysis. BMJ open. 2020;10(10):e037614. doi:10.1136/bmjopen-2020-037614
11. Gumus H, Demir A, Yukkaldiran A. Is mean platelet volume a predictive marker for the diagnosis of COVID‐19 in children? Int J Clin Pract. 2020;75(4):e13892. doi: 10.1111/ijcp.13892
12. Lippi G, Plebani M. Thecritical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 2020:58(7);1063–1069. doi: 10.1515/cclm-2020-0240
13. Bommenahalli Gowda S, Gosavi S, Ananda Rao A, Shastry S, Raj SC, Menon S, et al. Prognosis of COVID-19: red cell distribution width, platelet distribution width, and C-reactive protein. Cureus. 2021;13(2):e13078. doi: 10.7759/cureus.13078
14. Noris P, Melazzini F, Balduini CL. New roles for mean platelet volüme measurement in the clinical practice? Platelets. 2016;27(7):607-612. doi: 10.1080/09537104.2016.1224828
15. Henry BM, de Oliveira M, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-1028. doi: 10.1515/cclm-2020-0369
16. Güçlü E, Kocayiğit H, Okan HD, Erkorkmaz U, Yürümez Y, Yaylacı S, et al. Effect of COVID-19 on platelet count and its indices. Rev Assoc Med Bras. 2020;66(8):1122-1127. doi: 10.1590/1806-9282.66.8.1122
17. Ozcelik N, Ozyurt S, Yilmaz Kara B, Gumus A, Sahin U. The value of the platelet countand platelet indices in differentiation of COVID-19 and influenza pneumonia. J Med Virol. 2020;93(4):2221-2226. doi:10.1002/jmv.26645
18. Guner Ozenen G, Sahbudak Bal Z, Umit Z, Bilen NM, Yildirim Arslan S, Yurtseven A, et al. Demographic, clinical, and laboratory features of COVID-19 in children: The role of mean platelet volume in predicting hospitalization and severity. J Med Virol. 2021;93(5):3227–3237. doi: 10.1002/jmv.26902
19. Bg S, Gosavi S, Ananda Rao A, Shastry S, Raj SC, Sharma A, et al. Neutrophil-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios: prognostic significance in COVID-19. Cureus. 2021;13(1):e12622. doi: 10.7759/cureus.12622